Efficacy and safety of sarolaner (Simparica™) against fleas on dogs presented as veterinary patients in the United States.

@article{Cherni2016EfficacyAS,
  title={Efficacy and safety of sarolaner (Simparica™) against fleas on dogs presented as veterinary patients in the United States.},
  author={Judith A. Cherni and Sean P. Mahabir and Robert H. Six},
  journal={Veterinary parasitology},
  year={2016},
  volume={222},
  pages={43-8}
}
The efficacy and safety of a novel isoxazoline parasiticide, sarolaner (Simparica™), for the control of fleas on dogs was evaluated in a randomized, controlled clinical study conducted in 19 general veterinary practices throughout the United States. Four hundred and seventy nine (479) dogs from 293 households were enrolled. Each household was randomly assigned to treatment with either sarolaner oral tablets (Simparica™, Zoetis) at the proposed label dose or an approved comparator product at the… CONTINUE READING